Use of a New and Innovative Therapy for diabetes : Evaluation study

Use of a New and Innovative Therapy for diabetes : Evaluation study - UNITE Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011386

Enrollment

10000

Registered

2013-08-06

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Diagnosis of type 2 diabetes 2.Age => 20 years 3.Receiving oral diabetes drugs with a novel mechanism of action (including incretin-related drugs) under usual care 4.Receiving ongoing diet/exercise therapy.

Exclusion criteria

Exclusion criteria: 1.Current use of an insulin preparation 2.Diagnosis of type 1 diabetes 3.Current treatment with an investigational drug 4.Women who are pregnant, breastfeeding, or who hope to become pregnant 5.Patients whose participation is deemed inappropriate at the discretion of the attending physician.

Design outcomes

Primary

Measure	Time frame
1 Efficacy Change in HbA1c and body weight. Differential analysis by patients characteristics or concomitant drug. 2 Safety Adverse events and those rates of occurrence	—

Countries

Japan

Contacts

Public ContactNobuyuki Shihara

Japan Association for Diabetes Education and Care secretariat

shihara@nittokyo.or.jp03-3514-1721

Outcome results